Home › Chemicals & Product Safety › REACH Regulation

REACH Regulation

Regulation (EC) No 1907/2006 of the European Parliament and of the Council of 18 December 2006 concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH), establishing a European Chemicals Agency
32006R1907 · official text on EUR-Lex

Articles

Chapter 1 Aim, scope and application

• Article 1 — Aim and scope
• Article 2 — Application

Chapter 2 Definitions and general provision

• Article 3 — Definitions
• Article 4 — General provision

Chapter 1 General obligation to register and information requirements

• Article 5 — No data, no market
• Article 6 — General obligation to register substances on their own or in ►M3  mixtures ◄
• Article 7 — Registration and notification of substances in articles
• Article 8 — Only representative of a non-Community manufacturer
• Article 9 — Exemption from the general obligation to register for product and process orientated research and development (PPORD)
• Article 10 — Information to be submitted for general registration purposes
• Article 11 — Joint submission of data by multiple registrants
• Article 12 — Information to be submitted depending on tonnage
• Article 13 — General requirements for generation of information on intrinsic properties of substances
• Article 14 — Chemical safety report and duty to apply and recommend risk reduction measures

Chapter 2 Substances regarded as being registered

• Article 15 — Substances in plant protection and biocidal products
• Article 16 — Duties of the Commission, the Agency and registrants of substances regarded as being registered

Chapter 3 Obligation to register and information requirements for certain types of isolated intermediates

• Article 17 — Registration of on-site isolated intermediates
• Article 18 — Registration of transported isolated intermediates
• Article 19 — Joint submission of data on isolated intermediates by multiple registrants

Chapter 4 Common provisions for all registrations

• Article 20 — Duties of the Agency
• Article 21 — Manufacturing and import of substances
• Article 22 — Further duties of registrants

Chapter 5 Transitional provisions applicable to phase-in substances and notified substances

• Article 23 — Specific provisions for phase-in substances
• Article 24 — Notified substances

Chapter 1 Objectives and general rules

• Article 25 — Objectives and general rules

Chapter 2 Rules for non-phase-in substances and registrants of phase-in substances who have not pre-registered

• Article 26 — Duty to inquire prior to registration
• Article 27 — Sharing of existing data in the case of registered substances

Chapter 3 Rules for phase-in-substances

• Article 28 — Duty to pre-register for phase-in substances
• Article 29 — Substance Information Exchange Forums
• Article 30 — Sharing of data involving tests
• Article 31 — Requirements for safety data sheets
• Article 32 — Duty to communicate information down the supply chain for substances on their own or in ►M3  mixtures ◄ for which a safety data sheet is not required
• Article 33 — Duty to communicate information on substances in articles
• Article 34 — Duty to communicate information on substances and ►M3  mixtures ◄ up the supply chain
• Article 35 — Access to information for workers
• Article 36 — Obligation to keep information
• Article 37 — Downstream user chemical safety assessments and duty to identify, apply and recommend risk reduction measures
• Article 38 — Obligation for downstream users to report information
• Article 39 — Application of downstream user obligations

Chapter 1 Dossier evaluation

• Article 40 — Examination of testing proposals
• Article 41 — Compliance check of registrations
• Article 42 — Check of information submitted and follow-up to dossier evaluation
• Article 43 — Procedure and time periods for examination of testing proposals

Chapter 2 Substance evaluation

• Article 44 — Criteria for substance evaluation
• Article 45 — Competent authority
• Article 46 — Requests for further information and check of information submitted
• Article 47 — Coherence with other activities
• Article 48 — Follow-up to substance evaluation

Chapter 3 Evaluation of intermediates

• Article 49 — Further information on on-site isolated intermediates

Chapter 4 Common provisions

• Article 50 — Registrants' and downstream users' rights
• Article 51 — Adoption of decisions under dossier evaluation
• Article 52 — Adoption of decisions under substance evaluation
• Article 53 — Cost sharing for tests without an agreement between registrants and/or downstream users
• Article 54 — Publication of information on evaluation

Chapter 1 Authorisation requirement

• Article 55 — Aim of authorisation and considerations for substitution
• Article 56 — General provisions
• Article 57 — Substances to be included in Annex XIV
• Article 58 — Inclusion of substances in Annex XIV
• Article 59 — Identification of substances referred to in Article 57

Chapter 2 Granting of authorisations

• Article 60 — Granting of authorisations
• Article 61 — Review of authorisations
• Article 62 — Applications for authorisations
• Article 63 — Subsequent applications for authorisation
• Article 64 — Procedure for authorisation decisions

Chapter 3 Authorisations in the supply chain

• Article 65 — Obligation of holders of authorisations
• Article 66 — Downstream users

Chapter 1 General issues

• Article 67 — General provisions

Chapter 2 Restrictions process

• Article 68 — Introducing new and amending current restrictions
• Article 69 — Preparation of a proposal
• Article 70 — Agency opinion: Committee for Risk Assessment
• Article 71 — Agency opinion: Committee for Socio-economic Analysis
• Article 72 — Submission of an opinion to the Commission
• Article 73 — Commission decision
• Article 74 — Fees and charges
• Article 75 — Establishment and review
• Article 76 — Composition
• Article 77 — Tasks
• Article 78 — Powers of the Management Board
• Article 79 — Composition of the Management Board
• Article 80 — Chairmanship of the Management Board
• Article 81 — Meetings of the Management Board
• Article 82 — Voting of the Management Board
• Article 83 — Duties and powers of the Executive Director
• Article 84 — Appointment of the Executive Director
• Article 85 — Establishment of the Committees
• Article 86 — Establishment of the Forum
• Article 87 — Rapporteurs of Committees and use of experts
• Article 88 — Qualification and interests
• Article 89 — Establishment of the Board of Appeal
• Article 90 — Members of the Board of Appeal
• Article 91 — Decisions subject to appeal
• Article 92 — Persons entitled to appeal, time-limits, fees and form
• Article 93 — Examination and decisions on appeal
• Article 94 — Actions before the Court of First Instance and the Court of Justice
• Article 95 — Conflicts of opinion with other bodies
• Article 96 — The budget of the Agency
• Article 97 — Implementation of the budget of the Agency
• Article 98 — Combating fraud
• Article 99 — Financial rules
• Article 100 — Legal personality of the Agency
• Article 101 — Liability of the Agency
• Article 102 — Privileges and immunities of the Agency
• Article 103 — Staff rules and regulations
• Article 104 — Languages
• Article 105 — Duty of confidentiality
• Article 106 — Participation of third countries
• Article 107 — Participation of international organisations
• Article 108 — Contacts with stakeholder organisations
• Article 109 — Rules on transparency
• Article 110 — Relations with relevant Community bodies
• Article 111 — Formats and software for submission of information to the Agency
• Article 117 — Reporting
• Article 118 — Access to information
• Article 119 — Electronic public access
• Article 120 — Cooperation with third countries and international organisations
• Article 121 — Appointment
• Article 122 — Cooperation between competent authorities
• Article 123 — Communication to the public of information on risks of substances
• Article 124 — Other responsibilities
• Article 125 — Tasks of the Member States
• Article 126 — Penalties for non-compliance
• Article 127 — Report
• Article 128 — Free movement
• Article 129 — Safeguard clause
• Article 130 — Statement of reasons for decisions
• Article 131 — Amendments to the Annexes
• Article 132 — Implementing legislation
• Article 133 — Committee procedure
• Article 134 — Preparation of establishment of the Agency
• Article 135 — Transitional measures regarding notified substances
• Article 136 — Transitional measures regarding existing substances
• Article 137 — Transitional measures regarding restrictions
• Article 138 — Review
• Article 139 — Repeals
• Article 141 — Entry into force and application